News Image

Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Provided By GlobeNewswire

Last update: May 14, 2025

SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences:

Read more at globenewswire.com

MYRIAD GENETICS INC

NASDAQ:MYGN (6/10/2025, 8:00:01 PM)

After market: 5.23 0 (0%)

5.23

+0.04 (+0.77%)



Find more stocks in the Stock Screener

Follow ChartMill for more